Updates from The Motley Fool

Latest updates on Alnylam Pharmaceuticals from Fool.com.


Stock Performance

ALNY vs. S&P 500 | 2 Year Performance
ALNY 1-Day Stock Chart
ALNY 5-Day Stock Chart
ALNY 1-Month Stock Chart
ALNY 3-Month Stock Chart
ALNY 6-Month Stock Chart
ALNY 1-Year Stock Chart
ALNY 2-Year Stock Chart
ALNY 5-Year Stock Chart
View Interactive ALNY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Alnylam Pharmaceuticals.
Current Price: $67.57
Prev Close: $67.57
Open: $69.96
Bid: $66.58
Ask: $67.80
Day's Range: $67.18 - $70.89
52wk Range: $49.96 - $140.00
Volume: 1,238,242
Avg Vol 890,388
Market Cap: $5.73B
P/E (ttm): -17.47
EPS (ttm): -$4.04
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Alnylam Pharmaceuticals.
CAPS Rating 3 out of 5
 
379 Outperform
39 Underperform
CAPS All Stars
 
76 Outperform
16 Underperform

How do you think Alnylam Pharmaceuticals will perform against the market?



You pick for Alnylam Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John M. Maraganore, CEO

83% Approve

Based on 11 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Alnylam Pharmaceuticals.

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers